Novel Signaling Interface Constituted with Membrane Receptor-Like Kinases Emerged from the Study of Interaction and Transphosphorylation of BRI1 and BAK1

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|21|2393-2400

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.21, 2017-07, pp. : 2393-2400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 10, 2013-08 ,pp. : 1398-1406

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid Receptor-Like 1 (ORL1) Molecular “Road Map” to Understanding Ligand Interaction and Selectivity

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-04 ,pp. : 325-340

Bentham Science Publishers

Access to resources Recommend Favorite

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor

By Meunier J.-C.  

European Journal of Pharmacology, Vol. 340, Iss. 1, 1997-12 ,pp. : 1-15

Elsevier

Access to resources Recommend Favorite

Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

By Hawinkels Lukas JAC   Garcia de Vinuesa Amaya   ten Dijke Peter  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1371-1383

Informa Healthcare

Access to resources Recommend Favorite

Novel TNF receptor-like molecules and their biological uses

By  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1737-1739

Informa Healthcare

Access to resources Recommend Favorite